Are you a new member? Sign up now
Login area
| Sign up
close
OPSUMIT - 10mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C02KX04 | B | Macitentan - 10mg | 8898 | 140616/1 | OPSUMIT | 10mg | 30 | Tablet, film coated | Oral | Mersaco | Excella GmbH & Co KG | Germany | 201,006,231 L.L | 2.44 | E2 | Actelion Pharmaceuticals Ltd | Switzerland | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C02KX04 | B | Macitentan - 10mg | 8898/388 | 140616/1 | OPSUMIT | 10mg | 30 | Tablet, film coated | Oral | Mersaco | Excella GmbH & Co KG | Germany | L.L | 2.44 | E2 | Actelion Pharmaceuticals Ltd | Switzerland | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024